The death toll from listeria linked to tainted Boar’s Head deli meats has risen to three, with nine more cases of the bacterial illness reported in the outbreak, an update issued Thursday by the U.S. Centers for Disease Control and Prevention shows. The total case count is now 43. “All 43 people have been hospitalized… read on > read on >
All Food:
More Evidence That an Artificial Sweetener Poses Heart Risk
There’s more evidence to suggest that the common artificial sweetener erythritol might pose dangers to consumers’ hearts. The new study, involving 20 healthy adult volunteers, found that at doses commonly found in an erythritol-sweetened soda or muffin, the sweetener was linked to heightened activity of blood platelets, which could make clots more likely. No such… read on > read on >
Fish Oil Might Help Keep Cholesterol in Check
People with a genetic predisposition for high cholesterol can lower their levels by taking fish oil supplements, a new study shows. The results indicate that lifestyle can be a powerful influence on artery-clogging cholesterol, even if a person’s genetics tends to make those levels higher, researchers said. “Recent advances in genetic studies have allowed us… read on > read on >
Kids Worldwide Are Consuming More Sugary Drinks
Kids and teens around the world are consuming more sugary drinks, increasing their risk of future health problems, a new study finds. Young people consumed nearly 23% more sugar-sweetened beverages in 2018 compared to 1990, according to the report published Aug. 7 in the BMJ. “Sugary beverages increase weight gain and risk of obesity, so… read on > read on >
EPA Bans Vegetable Pesticide That Can Harm Fetuses
In an historic move, the Environmental Protection Agency on Tuesday banned the use of a pesticide that can harm fetuses. Known as dimethyl tetrachloroterephthalate (DCPA or Dacthal), the weedkiller is used on a variety of crops, including broccoli, onions, kale, Brussels sprouts and cabbage. However, when a pregnant woman is exposed to the chemical, it… read on > read on >
Cost Keeps Many Who Need Them From Getting New Weight-Loss Meds
WEDNESDAY, Aug. 7, 2024 (HealthDay news) — Medicare and Medicaid patients are less likely to get cutting-edge weight-loss drugs than people with private insurance are, a new study finds. Medicaid accounted for less than 10% of semaglutide (Ozempic, Wegovy) prescription fills in 2023, researchers found. Similarly, Medicare Part D accounted for less than 29% of… read on > read on >
4 Tips to Keeping Your Gut Healthy and Free of IBD
Almost 2.4 million Americans are thought to suffer from the pain and disability of inflammatory bowel disorder (IBD), a type of autoimmune illness that includes ulcerative colitis and Crohn’s disease. You can avoid adding to that number by following a few simple steps to a healthy gut, said Dr. Victor Chedid, a gastroenterologist and IBD… read on > read on >
Brand of Kratom Tied to One Death, Many Severe Illnesses, FDA Warns
Millions of Americans use the opioid-like herbal supplement known as kratom, but evidence of its dangers continue to mount. The U.S. Food and Drug Administration has issued another alert for consumers to stay away from one brand of kratom in particular, OPMS Black Liquid Kratom. “The FDA recently received an adverse event report of a… read on > read on >
Worried About Bird Flu or Salmonella? Your Cooking Thermometer Could Be Life Saver
Folks worried about bird flu, salmonella and other foodborne illnesses have a simple solution at hand – simply use a cooking thermometer to make sure food is well-cooked. But only about 1 in 4 Americans (27%) use one either “often” or “all the time” to check whether meat, poultry or fish has reached a temperature… read on > read on >
Legit Ozempic Sales Soar While Counterfeits Put Patients in Danger
Two new studies show how eager Americans are to obtain either safe, legitimate versions of Ozempic or counterfeit and potentially dangerous forms of the diabetes/weight-loss drug. One study found U.S. prescriptions and refills of Ozempic (semaglutide) soaring over the past three years, jumping almost five-fold (392%) between early 2021 and the end of 2023. Ozempic’s… read on > read on >